As the demand for personalized medical treatment increases, there’s a similarly growing need for laboratories that can help medical professionals understand patients’ unique makeups and identify markers and issues on a molecular level. Diagnostic Solutions Laboratory CEO Tony Hoffman appears on Worldwide Business with kathy ireland® to discuss his company’s cutting-edge methodology that relies on artificial intelligence and proven techniques to produce reliable, accurate and actionable results.

Diagnostic Solutions Laboratory‘s product portfolio includes proprietary tests such as the GI-MAP, a DNA/PCR-based analysis of each individual’s gut microbiota. Research indicates the information gathered could help identify the root problem of some chronic diseases and inflammatory conditions, including autoimmune disorders and cardiovascular concerns. For physicians, it’s a chance to get additional insight into each patient, allowing for more informed decisions regarding everything from diagnoses to treatment options. For patients, it’s an opportunity to capitalize on more personalized medicine that could lead to an increase in overall health and well-being.